Cargando…
Using an Automated Algorithm to Identify Potential Drug-Induced Liver Injury Cases in a Pharmacovigilance Database
INTRODUCTION: Drug-induced liver injury (DILI) is the most frequent cause of acute liver failure in North America and Europe, but it is often missed because of unstandardized diagnostic methods and criteria. This study aimed to develop and validate an automated algorithm to identify potential DILI c...
Autores principales: | Pineda Salgado, Liliam, Gupta, Ritu, Jan, Michael, Turkoglu, Osman, Estilo, Alvin, George, Vinu, Rahman, Mirza I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408072/ https://www.ncbi.nlm.nih.gov/pubmed/34319549 http://dx.doi.org/10.1007/s12325-021-01856-x |
Ejemplares similares
-
Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study
por: Estilo, Alvin, et al.
Publicado: (2021) -
Evaluating the impact of a Risk Evaluation and Mitigation Strategy with tolvaptan to monitor liver safety in patients with autosomal dominant polycystic kidney disease
por: Estilo, Alvin, et al.
Publicado: (2022) -
Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
por: Hey-Hadavi, Juliana, et al.
Publicado: (2021) -
Potential and Pitfalls of Pharmacovigilance Databases in Oncology
por: Schlam, Ilana, et al.
Publicado: (2023) -
Pharmacoenvironmentology – a component of pharmacovigilance
por: Rahman, Syed Ziaur, et al.
Publicado: (2007)